Originally from India, Krushna received his M.Tech degree from Indian Institute of Technology, India and PhD degree from University of Illinois at Chicago, USA. In his graduate study with Dr. Nissim Hay he studied the contributions of metabolic enzymes in oncogenesis process in different mouse models of cancer. In Bardeesy lab he is currently studying metabolic reprogramming in the progression of pancreatic cancer precursors.
Jia-Chi Yeo, Ph.D. | firstname.lastname@example.org
Jia-Chi is from Singapore and he received his Ph.D. in Biological Sciences from the Nanyang Technological University. During his graduate studies, he studied the role of Klf2 and Mek/Erk-signaling during mouse ground state pluripotency. Joining the Bardeesy Lab in 2015 for his post-doctoral research, Jia-Chi is currently researching on the role of transcriptional/epigenetic regulation in cholangiocarcinoma.
Leah Liu, Ph.D. | Leah.Liu@mgh.harvard.edu
Leah completed her BS at Penn State University and her PhD in Biological and Biomedical Sciences at Harvard University, where she studied liver development and liver injury using the zebrafish model. In the Bardeesy Lab, Leah is studying the role of FGFR2 mutations in cholangiocarcinoma.
Lei Shi, Ph.D. | LSHI7@mgh.harvard.edu
Lei received his BS degrees from China Agricultural University and Purdue University. He then obtained his PhD degree in Biochemistry at University of Texas Southwestern Medical Center. Under the guidance of Dr. Benjamin Tu, he studied the metabolic regulation of cell growth and quiescence in yeast. Upon completion of his PhD degree, he joined the Bardeesy lab and continued to pursue his interest in metabolism and biochemistry. Currently, he is studying the biochemical mechanisms of IDH mutations in cholangiocarcinoma.
Krishna Tummala, Ph.D. | email@example.com
Krishna did his MS in Biotechnology at Indian Institute of Technology Roorkee. He continued his graduate training at Spanish National Cancer Research Centre (CNIO) on liver cancer under the supervision of Dr. Nabil Djouder. His PhD work focused on the cellular and molecular mechanisms of hepatocarcinogenesis in vivo. He joined Dr. Bardeesy lab in April 2016 to study the role of sub-cellular organelles in pancreatic cancer development using sophisticated in vitro cell systems.
Vajira received his BS degree in Biochemistry and Molecular Biology from University of Colombo, Sri Lanka. He then obtained his Ph.D. in Biochemistry under the supervision of Dr. Joshua Andersen at Brigham Young University, Provo, Utah. His Ph.D. thesis focused on the changes in phosphoproteome as a response to tumor hypoxia. He joined the Bardeesy lab in 2017 to study tumorigenesis and progression of pancreatic cancer using in vivo and in vitro systems.
The Bardeesy Lab at Massachusetts General Hospital Cancer Center and Harvard Medical School focuses on the biology of pancreatic cancer and cholangiocarcinoma.